Farrow Jeffrey S
Insider CIK 1405253 · HPTX CFO & Secretary · ZSPH Chief Financial Officer · GBT Chief Financial Officer · TARS See Remarks · ACHV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 16,700 | — | $0 | 16,700 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 16,700 | — | $0 | 16,700 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-06-16 | 2026-06-17 | 14,396 | $60.95 | $877.4K | 56,801 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-06-15 | 2026-06-17 | 27,881 | — | $0 | 27,882 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-06-15 | 2026-06-17 | 27,881 | — | $0 | 71,197 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-05-29 | 2026-06-02 | 47,250 | — | $0 | 47,250 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-19 | 2026-03-19 | 2,186 | $67.00 | $146.5K | 43,316 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-18 | 2026-03-19 | 2,133 | $68.71 | $146.6K | 45,502 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-17 | 2026-03-19 | 2,111 | $69.42 | $146.5K | 47,635 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 5,022 | — | $0 | 15,067 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 8,020 | — | $0 | 16,040 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-03-15 | 2026-03-17 | 13,042 | — | $0 | 49,746 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 30,724 | — | $0 | 30,724 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 19,306 | — | $0 | 19,306 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-06-17 | 2025-06-18 | 13,608 | $40.42 | $550.0K | 36,704 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-06-16 | 2025-06-18 | 27,881 | — | $0 | 55,763 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-06-16 | 2025-06-18 | 27,881 | — | $0 | 50,312 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-20 | 2025-03-20 | 1,186 | $50.11 | $59.4K | 22,431 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-19 | 2025-03-20 | 1,254 | $47.40 | $59.4K | 23,617 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-18 | 2025-03-20 | 1,284 | $46.29 | $59.4K | 24,871 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-17 | 2025-03-18 | 8,019 | — | $0 | 24,060 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-03-15 | 2025-03-18 | 8,019 | — | $0 | 26,155 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 20,089 | — | $0 | 20,089 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 30,628 | — | $0 | 30,628 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2024-06-18 | 2024-06-20 | 10,445 | $27.47 | $286.9K | 18,136 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-06-17 | 2024-06-20 | 27,881 | — | $0 | 83,644 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-06-17 | 2024-06-20 | 27,881 | — | $0 | 28,581 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 32,079 | — | $0 | 32,079 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 47,500 | — | $0 | 47,500 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-04-24 | 2023-04-26 | 163,397 | — | $0 | 163,397 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-04-24 | 2023-04-26 | 111,525 | — | $0 | 111,525 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 28,628 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 120,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 35,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 40,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 38,500 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 38,739 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 10,299 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 3,125 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 9,060 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 13,814 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 15,460 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 26,454 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 42,400 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 26,739 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-27 | 2022-09-29 | 23,653 | — | $0 | 10,299 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-27 | 2022-09-29 | 23,653 | $16.40 | $387.9K | 26,739 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 2,208 | — | $0 | 15,460 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 2,763 | — | $0 | 13,814 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 2,208 | — | $0 | 36,412 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-09-01 | 2022-09-06 | 1,885 | $68.15 | $128.5K | 34,527 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2022-09-01 | 2022-09-06 | 31,441 | $68.00 | $2.14M | 3,086 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 2,763 | — | $0 | 34,204 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,020 | — | $0 | 9,060 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,125 | — | $0 | 3,125 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-08-01 | 2022-08-03 | 6,145 | — | $0 | 33,567 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-08-01 | 2022-08-03 | 2,126 | $32.40 | $68.9K | 31,441 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 17,668 | — | $0 | 17,668 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 17,668 | — | $0 | 17,668 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-03-01 | 2022-03-03 | 2,763 | — | $0 | 16,577 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 28,628 | — | $0 | 28,628 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-03-01 | 2022-03-03 | 1,315 | $29.87 | $39.3K | 27,422 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-03-01 | 2022-03-03 | 2,763 | — | $0 | 28,737 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,020 | — | $0 | 12,080 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,125 | — | $0 | 6,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 2,875 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-02-01 | 2022-02-03 | 9,020 | — | $0 | 30,480 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-02-01 | 2022-02-03 | 4,506 | $29.33 | $132.2K | 25,974 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-09-01 | 2021-09-03 | 2,762 | — | $0 | 19,340 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-09-01 | 2021-09-03 | 2,762 | — | $0 | 22,830 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-09-01 | 2021-09-03 | 1,370 | $29.85 | $40.9K | 21,460 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,020 | — | $0 | 15,100 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,125 | — | $0 | 9,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 2,875 | — | $0 | 2,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 3,020 | — | $0 | 15,100 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 2,875 | — | $0 | 2,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 3,125 | — | $0 | 9,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-08-03 | 9,020 | — | $0 | 24,422 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-08-03 | 4,354 | $27.33 | $119.0K | 20,068 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-09-24 | 4,354 | $27.33 | $119.0K | 20,068 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-09-24 | 9,020 | — | $0 | 24,422 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 22,102 | — | $0 | 22,102 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 38,739 | — | $0 | 38,739 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,063 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,020 | — | $0 | 18,120 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 2,875 | — | $0 | 5,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,125 | — | $0 | 12,500 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-02-01 | 2021-02-03 | 5,865 | $49.49 | $290.3K | 15,402 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-02-01 | 2021-02-03 | 12,083 | — | $0 | 21,267 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 2,875 | — | $0 | 8,625 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 3,020 | — | $0 | 21,140 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 3,125 | — | $0 | 15,625 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 3,062 | — | $0 | 3,063 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-08-01 | 2020-08-04 | 5,946 | $67.48 | $401.2K | 9,184 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-08-01 | 2020-08-04 | 12,082 | — | $0 | 15,130 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-07-13 | 2020-07-15 | 15,208 | $75.00 | $1.14M | 3,048 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-06-09 | 2020-06-11 | 15,208 | $67.00 | $1.02M | 18,256 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-01 | 2020-06-03 | 42,400 | — | $0 | 42,400 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 24,160 | — | $0 | 24,160 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 38,500 | — | $0 | 38,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 3,063 | — | $0 | 6,125 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 2,875 | — | $0 | 11,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 3,125 | — | $0 | 18,750 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-02-01 | 2020-02-04 | 4,398 | $65.26 | $287.0K | 33,464 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-02-01 | 2020-02-04 | 9,063 | — | $0 | 37,862 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-12-13 | 2019-12-17 | 5,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-12-13 | 2019-12-17 | 5,000 | — | $0 | 31,278 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-12-13 | 2019-12-17 | 2,479 | $76.88 | $190.6K | 28,799 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 3,062 | — | $0 | 9,188 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 3,125 | — | $0 | 21,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 2,875 | — | $0 | 14,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-08-01 | 2019-08-05 | 9,062 | — | $0 | 29,699 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-08-01 | 2019-08-05 | 3,421 | $54.25 | $185.6K | 26,278 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-04-08 | 2019-04-10 | 2,000 | — | $0 | 5,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-04-08 | 2019-04-10 | 2,000 | — | $0 | 21,329 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-04-08 | 2019-04-10 | 692 | $58.51 | $40.5K | 20,637 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-02-01 | 2019-02-05 | 3,063 | — | $0 | 12,250 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-02-01 | 2019-02-05 | 2,875 | — | $0 | 17,250 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-02-01 | 2019-02-05 | 2,164 | $48.44 | $104.8K | 19,329 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-02-01 | 2019-02-05 | 5,938 | — | $0 | 21,493 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-11-27 | 2018-11-28 | 3,048 | — | $0 | 33,952 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-11-27 | 2018-11-28 | 3,048 | $16.40 | $50.0K | 15,555 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-01 | 2018-08-03 | 3,062 | — | $0 | 15,313 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-01 | 2018-08-03 | 2,875 | — | $0 | 20,125 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-08-01 | 2018-08-03 | 5,937 | — | $0 | 14,907 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-08-01 | 2018-08-03 | 2,400 | $43.15 | $103.6K | 12,507 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-14 | 2018-02-16 | 2,000 | — | $0 | 7,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-14 | 2018-02-16 | 692 | $62.30 | $43.1K | 8,970 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-14 | 2018-02-16 | 2,000 | — | $0 | 9,662 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-01 | 2018-02-02 | 3,063 | — | $0 | 18,375 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 23,000 | — | $0 | 23,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-01 | 2018-02-02 | 1,060 | $59.60 | $63.2K | 7,662 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-01 | 2018-02-02 | 3,063 | — | $0 | 8,722 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-31 | 2018-02-02 | 2,000 | — | $0 | 9,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-31 | 2018-02-02 | 2,000 | — | $0 | 6,351 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-31 | 2018-02-02 | 692 | $57.90 | $40.1K | 5,659 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-24 | 2018-01-26 | 2,000 | — | $0 | 11,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-24 | 2018-01-26 | 683 | $58.15 | $39.7K | 4,351 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-24 | 2018-01-26 | 2,000 | — | $0 | 5,034 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-16 | 2018-01-18 | 2,000 | — | $0 | 13,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-16 | 2018-01-18 | 877 | $52.10 | $45.7K | 3,034 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-16 | 2018-01-18 | 2,000 | — | $0 | 3,911 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-08-11 | 2017-08-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-08-01 | 2017-08-03 | 3,062 | — | $0 | 21,438 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2017-08-01 | 2017-08-03 | 1,151 | $25.10 | $28.9K | 1,911 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-08-01 | 2017-08-03 | 3,062 | — | $0 | 3,062 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 37,000 | — | $0 | 37,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 24,500 | — | $0 | 24,500 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 7,100 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 77,900 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 32,500 | $46.00 | $1.50M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 23,346 | $46.00 | $1.07M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 14,371 | $46.00 | $661.1K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 39,500 | $46.00 | $1.82M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-08 | 38,000 | $46.00 | $1.75M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | U Tender | 2015-05-07 | 2015-05-08 | 878 | $46.00 | $40.4K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer | 2015-05-07 | 2015-05-08 | 120,777 | $46.00 | $5.56M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer | 2015-05-07 | 2015-05-08 | 22,687 | $46.00 | $1.04M | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise deriv | 2015-05-01 | 2015-05-05 | 53,184 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise deriv | 2015-05-01 | 2015-05-05 | 24,630 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise deriv | 2015-05-01 | 2015-05-05 | 17,704 | — | $0 | 23,346 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise deriv | 2015-05-01 | 2015-05-05 | 629 | — | $0 | 14,371 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise deriv | 2015-05-01 | 2015-05-05 | 24,630 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise | 2015-05-01 | 2015-05-05 | 17,704 | $7.31 | $129.4K | 143,773 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise | 2015-05-01 | 2015-05-05 | 53,184 | $4.08 | $217.0K | 126,069 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise | 2015-05-01 | 2015-05-05 | 24,630 | $1.28 | $31.5K | 48,255 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise | 2015-05-01 | 2015-05-05 | 24,630 | $1.28 | $31.5K | 72,885 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | M Exercise | 2015-05-01 | 2015-05-05 | 629 | $10.95 | $6.9K | 144,402 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2015-02-09 | 2015-02-10 | 32,500 | — | $0 | 32,500 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2015-02-09 | 2015-02-10 | 18,000 | — | $0 | 23,625 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | F Tax w/h | 2015-01-02 | 2015-01-05 | 685 | $24.28 | $16.6K | 5,625 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2014-03-11 | 2014-03-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2014-03-11 | 2014-03-13 | 6,250 | — | $0 | 6,250 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2013-04-15 | 2013-05-01 | 39,500 | — | $0 | 39,500 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2012-10-16 | 2012-10-18 | 15,000 | — | $0 | 15,000 | SEC↗ |